Britain's GW Pharma to cancel London listing

Oct 19 (Reuters) - Britain's GW Pharmaceuticals Plc said it planned to cancel its listing in London's junior market and would retain listing of its American Depositary Receipts (ADRs) on New York's Nasdaq to simplify trading and cut expenses of dual listing.